The genes preferentially mutated in metastases were MYLK, PEAK1, SLC2A4RG, EVC2, XIRP2, PALB2, and ESR1 (five of which are not significantly mutated in any type of human primary cancer). This evidence concerns the gene MYLK and cancer.